ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PACB Pacific Biosciences of California Inc

1.84
0.08 (4.55%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Pacific Biosciences of California Inc NASDAQ:PACB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.08 4.55% 1.84 1.81 1.98 2.045 1.75 1.87 14,517,069 05:00:11

Pacific Biosciences of California, Inc. First Quarter 2017 Financial Results Call

18/04/2017 5:52pm

GlobeNewswire Inc.


Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Pacific Biosciences of C... Charts.

Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its First Quarter 2017 Financial Results on Wednesday, April 26, 2017, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at:  http://investor.pacificbiosciences.com/.

Date: April 26, 2017

Time: 4:30pm ET

Listen via Internet: http://investor.pacificbiosciences.com/

Toll-free: 888.366.7247

International: 707.287.9330

Audience Passcode: 1033-2877

Replay: http://investor.pacificbiosciences.com

About Pacific BiosciencesPacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and is the only DNA sequencing technology that provides the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.

Pacific Biosciences
Trevin Rard
650.521.8450
ir@pacificbiosciences.com

1 Year Pacific Biosciences of C... Chart

1 Year Pacific Biosciences of C... Chart

1 Month Pacific Biosciences of C... Chart

1 Month Pacific Biosciences of C... Chart

Your Recent History

Delayed Upgrade Clock